Immunoproliferative small intestinal disease (IPSID), also known as alpha heavy chain disease, is a rare type of gastrointestinal lymphoma primarily affecting the small intestine. This condition is characterized by the uncontrolled growth of abnormal plasma cells that produce defective alpha heavy chain immunoglobulins.
IPSID typically presents with symptoms such as chronic diarrhea, weight loss, abdominal pain, and malabsorption. It is more prevalent in areas with poor sanitation and is often associated with chronic infections, such as Campylobacter jejuni or Helicobacter pylori. However, the exact cause of IPSID is still not fully understood.
To diagnose IPSID, various tests are performed, including blood tests, stool analysis, endoscopy, and biopsy. Blood tests help in identifying abnormal levels of proteins, while a biopsy of the small intestine provides important information about the presence of abnormal plasma cells.
Here are some key points about IPSID:
It is important to note that this article provides a general overview of immunoproliferative small intestinal disease. If you suspect you or someone you know may have IPSID, it is crucial to consult a healthcare professional for accurate diagnosis and appropriate treatment.
Immunoproliferative small intestinal disease (IPSID) is a rare condition characterized by abnormal cell growth in the small intestine. It primarily affects individuals in Mediterranean and Middle Eastern countries. If you or someone you know has been diagnosed with IPSID, it's crucial to understand the available treatm...
To see full information about treatment please Sign up or Log in